InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
Subscribe Login/Register
S&P 500
5,615.35
(
0.55%
)
US TECH 100
19,804.00
(
0.64%
)
Dow Jones
40,000.90
(
0.62%
)
Brent Oil
84.57
(
0.00%
)
Bitcoin
58,620.77
(
1.26%
)
Post# of 19309
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

bensf888

Send PM Follow Ignore
Followers 0
Posts 5
Boards Moderated 0
Alias Born 02/24/2006

bensf888

Re: floblu14 post# 886

Wednesday, 09/27/2006 5:16:35 PM

Wednesday, September 27, 2006 5:16:35 PM

Post# of 19309


From
http://v3.espacenet.com/textdoc?DB=EPODOC&IDX=WO2006088447&F=0

"The current invention relates to the development and methods of use of a recombinant agonistic antibody anti-human CD137, and glycosylation variants thereof."

GTCB can control glycosylation to create variants, it seems?

Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.

Sign Up